Addiction Medicine 2020

Conference Rewind

We know not everyone can make our popular Addiction Medicine Conferences, so we’re bringing them to you! We’re making these highly-reviewed courses from leading experts in the field accessible all year round. For just $50, you can attend six virtual courses – anywhere, anytime – and earn 4.5 CME.
  • Cogitative Traits 1
    1. Participants will develop an understanding of the risk factors for addiction.
    2. Participants will be able to understand the neurobiology and cognitive aspects of addiction.
    3. Participants will have an awareness of evidence-based approaches to the treatment of addiction based on these behavioral and cognitive variables.
  • Alcohol Use Disorders 1
    1. Define AUDs as a spectrum of behaviors and outline the diagnostic steps to identifying a particular individual’s position on that spectrum.
    2. Provide an overview of intervening along this spectrum, including attention to SBIRT and medications to assist treatment.
    3. Describe MI oriented responses to someone with moderate to severe AUD who expresses a desire to decrease rather than stop his or her drinking.
    4. Outline current evidence related to clinical approaches to “moderation management” including the potential role of medications.
  • Psychosocial Support 1
    1. Understand reactions to the COVID-19 pandemic in light of the Disaster Response Phases timeline.
    2. Recognize the signs of Critical Incident Stress.
    3. Understand risk factors for developing PTSD and other post-disaster pathologies.
    4. Identify strategies to promote resilience and positive coping (for patients and ourselves).
  • Vaping 1
    1. Understand vaping and how it differs from smoking tobacco.
    2. Understand the scope of the vaping problem.
    3. Understand teenage use –through stories from our schools.
    4. Understand vaping related illness – what is known and unknown.
    5. Understand treatment for tobacco use disorders in teens.
    6. Be aware of resources.
  • Cannabis/CBD for Pain 1
    1. What do we know about the utility of cannabis products for pain and anxiety?
    2. What can we learn from states that have increased access about how to use these products clinically?
    3. How does that need to be adapted in states with limited access or access only to illicit, recreational cannabis?CBD products are available in NC and other states in this region: What do we know about their effectiveness? How can those products be used clinically?
  • Hep C and HIV PrEP 1
    1. Identify patients with risk behaviors for HIV and Hepatitis C infection.
    2. Describe the necessary work-up required prior to prescribing Hepatitis C treatment and HIV prevention.
    3. Choose appropriate therapies based on clinical evaluation and patient-specific criteria.
    4. Design a follow-up plan to optimize patient outcomes.
    5. Develop a strategy to implement services in the primary care setting.

Learn more about our conferences and educational opportunities

Addiction Medicine Spring and Fall Conferences provide up-to-date substance use related education, applicable across general medical as well as addiction specialty practices.